PHARMACEUTICAL STUDIES ON THE EFFECT OF DIFFERENT POLOXAMERS ON THE DISOLUTION RATE OF BSC CLASS II ANTIGOUT MODEL DRUG (FEBUXOSTAT)

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 11

Abstract

The aim of the present work was to increase the dissolution rate of febuxostat (FXT) (Xanthine oxidase enzyme inhibitor), a practically water-insoluble drug using solid dispersion with hydrophilic polymers. Two commercially available poloxamer grades (poloxamer 188 and poloxamer407) were selected, and solid dispersions containing different weight ratio of poloxamers and FXT were prepared by kneading method. The kneading method was used to prepare FXT/ poloxamer solid dispersions due to the good results obtained in previous researches reported by many researchers. FXT has low, variable oral bioavailability and poor water solubility with slow dissolution and peripheral degradation. The prepared solid dispersions was characterized by drug content, in vitro release study, Fourier Transform Infra-Red (FT-IR), Scanning electron microscopy (SEM) and Differential scanning calorimetry (DSC). The results revealed that FXT solid dispersion using poloxamer 188 and poloxamer 407 increased the dissolution rate in comparison to unprocessed FXT. Further, the thermal analysis showed that the FXT enhanced dissolution was due to FXT crystal pattern changes. Moreover, the results revealed that, FXT dissolution rate was inversely proportional with poloxamer ratio as its increase, drug dissolution decreased. SEM image revealed that the solid dispersion granules did not have a perfect spherical shape and a rugged surface. It could be concluded that, solid dispersion technique was a powerful method that enhanced the dissolution rate of FXT utilizing kneading method and poloxamer 188 in 1:1 drug/ polymer w/w ratio was effectively enhanced the dissolution rate of FXT more than poloxamer 407.

Authors and Affiliations

Dr. Ahmed A. El Shenawy

Keywords

Related Articles

IMPLEMENTATION OF A NEW SOCIO-ECONOMIC MODEL OF INNOVATION MANAGEMENT FOR ARTISANAL, MICRO, SMALL AND MEDIUM COMPANIES IN THE PHARMACEUTICAL FIELD IN COSTA RICA

In 2014, the structure of a socioeconomic model of innovation strategies applied for artisanal, micro, small and medium companies (ARPYMMES in spanish), was published in the “V Congreso Universidad” developed in La Havan...

ANAESTHETIC TECHNIQUES IN DAY CASE UROLOGICAL SURGERIES IN BENUE STATE UNIVERSITY TEACHING HOSPITAL (BSUTH), MAKURDI, NIGERIA.

Background: The global economic constraints and increasing financial awareness has led to an increase in day case surgeries because there is reduction in healthcare cost. Day case surgery also gives rise to reduction of...

PHYTOCHEMISTRY AND ANTIMICROBIAL EFFICACY OF THE CRUDE, FLAVONOIDS AND SAPONINS EXTRACTS OF ARISTOLOCHIA ALBIDA, CALOTROPIS PROCERA AND ZIZIPHUS SPINA-CHRISTI AGAINST SOME PATHOGENIC MICROORGANISMS

The use of herbs to treat diseases is almost universal among non-industrialized societies including Nigeria and is often more affordable than purchasing modern pharmaceuticals. Medicinal plants, therefore still remain fe...

ANTI-DIABETIC DRUG COMBINATIONS IN TYPE-II DIABETES MELLITUS AND OUTCOME OF PATIENTS’ COMPLIANCE ON FASTING BLOOD GLUCOSE CONTROL

Background: Patients’ adherences to medication and other treatment plans is cornerstone toward attaining glycaemic control in type II diabetes mellitus (T2DM). Objectives: The study assessed the effects of patient compli...

MOLECULAR CHARACTERIZATION OF LASB GENE OF PSEUDOMONAS AERUGINOSA ISOLATED FROM CLINICAL AND ENVIRONMENTAL SOURCES IN THI-QAR PROVINCE

The study was conducted through a period from March to September 2016.A total of 365 samples from hospital environment and various clinical cases of different patients were randomly collected and examined for detection o...

Download PDF file
  • EP ID EP672261
  • DOI -
  • Views 179
  • Downloads 0

How To Cite

Dr. Ahmed A. El Shenawy (2019). PHARMACEUTICAL STUDIES ON THE EFFECT OF DIFFERENT POLOXAMERS ON THE DISOLUTION RATE OF BSC CLASS II ANTIGOUT MODEL DRUG (FEBUXOSTAT). European Journal of Biomedical and Pharmaceutical Sciences, 6(11), 17-22. https://europub.co.uk./articles/-A-672261